Histamine H3 receptor agents, preparation and therapeutic uses

Details for Australian Patent Application No. 2005230881 (hide)

Owner Eli Lilly and Company

Inventors Takakuwa, Takako; Finn, Terry Patrick; Finley, Don Richard; Hornback, William Joseph; Vaught, Grant Mathews; Jesudason, Cynthia Darshini; Hipskind, Philip Arthur; Beavers, Lisa Selsam; Pickard, Richard Todd; Gadski, Robert Alan

Agent Spruson & Ferguson

Pub. Number AU-B-2005230881

PCT Pub. Number WO2005/097740

Priority 60/617,101 08.10.04 US; 60/558,542 01.04.04 US

Filing date 25 March 2005

Wipo publication date 20 October 2005

Acceptance publication date 31 March 2011

International Classifications

C07D 405/10 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097740 Priority application(s): WO2005/097740

31 March 2011 Application Accepted

  Published as AU-B-2005230881

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230886-Prokineticin 2beta peptide and its use

2005230878-2-aminothiazole compounds useful as aspartyl protease inhibitors